Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience

1. Fortea-Ormaechea, J.I.
2. González-Lama, Y.
3. Casis, B.
4. Chaparro, M.
5. López Serrano, P.
6. Van Domselaar, M.
7. Bermejo, F.
8. Pajares, R.
9. Ponferrada, Á.
10. Vera, M.I.
11. Martínez Montiel, P.
12. Gisbert, J.P.
13. Pérez-Calle, J.L.
14. López San Román, A.
15. Abreu, L.
16. Menchén, L.A.
17. Marn-Jimenez, I.